Article
Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer.
Pharmacogenetics - 1 Feb 2000
Watanabe J, Shimada T, Gillam E M, Ikuta T, Suemasu K, Higashi Y, Gotoh O, Kawajiri K
Abstract excerpt
Cytochrome P450 1B1 (CYP1B1) participates in the metabolic activation of a number of procarcinogens including benzo[a]pyrene and the hydroxylation of 17beta-estradiol at the C-4 position. In this study, we investigated the association between CYP1B1 genetic polymorphism and breast or lung cancer incidence. The Ala-Ser polymorphism at codon 119 in presumed substrate recognition site 1 was significantly associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
